CXCR2 expression on neutrophils is upregulated during the relapsing phase of ocular Behçet disease

Current Eye Research

Volumn 30, Issue 3, 2005, Pages 195-203

  Qiao, Hong ^a   Sonoda, Koh Hei ^a   Ariyama, Akiko ^a   Kuratomi, Yuichiro ^a   Kawano, Yoh Ichi ^b   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HAMANOMACHI HOSPITAL   (Japan)

Author keywords

ELR positive chemokine receptor; Leukocytes; Prednisolone; Uveitis

Indexed keywords

CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; PREDNISOLONE;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKOCYTE; LYMPHOCYTE; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE; REMISSION; STEROID THERAPY; UVEITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; BEHCET SYNDROME; BIOLOGICAL MARKERS; COLCHICINE; DRUG THERAPY, COMBINATION; FLOW CYTOMETRY; HUMANS; NEUTROPHILS; PREDNISOLONE; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; RECURRENCE; UP-REGULATION;

EID: 17144413335     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680490904331     Document Type: Article

References (32)

1. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet's disease. N Engl J Med. 1999;341:1284-1291.
2. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behcet's disease. Int J Dermatol. 2003;42:346-351.
3. Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H, Serdaroglu S, Ersanli M, Ulku BY, Muftuoglu AU. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behcet's syndrome. Ann Rheum Dis. 1984;43:783-789.
4. Evereklioglu C, Turkoz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators Inflamm. 2002;11:87-93.
5. Itoh R, Takenaka T, Okitsu-Negishi S, Matsushima K, Mizoguchi M. Interleukin 8 in Behcet's disease. J Dermatol. 1994;21:397-404.
6. Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis CHC. Serum of patients with Behcet's disease induces classical (proinflammatory) activation of human macrophages in vitro. Dermatology. 2003;206:225-232.
7. Jones SA, Dewald B, Clark-Lewis I, Baggiolini M. Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2. J Biol Chem. 1997;272:16166-16169.
8. Premack BA, Schall TJ. Chemokine receptors: Gateways to inflammation and infection. Nat Med. 1996;2:1174-1178.
9. Rollins BJ. Chemokines. Blood. 1997;90:909-928.
10. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 2000;18:217-242.
11. Mellado M, Rodriguez-Frade JM, Manes S, Martinez AC. Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation. Annu Rev Immunol. 2001;19:397-421.
12. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines: CXC and CC chemokines. Adv Immunol. 1994;55:97-179.
13. Proost P, De Wolf-Peeters C, Conings R, Opdenakker G, Billiau A, Van Damme J. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J Immunol. 1993;150:1000-1010.
14. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI. Characterization of two high affinity human interleukin-8 receptors. J Biol Chem. 1992;267:16283-16287.
15. Schumacher C, Clark-Lewis I, Baggiolini M, Moser B. High- and low-affinity binding of Gro alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci U S A. 1992;89:10542-10546.
16. Evereklioglu C, Turkoz Y, Inaloz HS, Ozbek E, Cekmen M. Increased nitric oxide production in patients with Behcet's disease: Is it a new activity marker? J Am Acad Dermatol. 2002;46:50-54.
17. L'Heureux GP, Bourgoin S, Jean N, McColl SR, Naccache PH. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: Interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity. Blood. 1995;85:522-531.
18. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci U S A. 1996;93:6682-6686.
19. Bruhl H, Wagner K, Kellner H, Schattenkirchner M, Schlondorff D, Mack M. Surface expression of CC- and CXC-chemokine receptors on leucocyte subsets in inflammatory joint diseases. Clin Exp Immunol. 2001;126:551-559.
20. Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335:1078-1080.
21. Wang LM, Kitteringham N, Mineshita S, Wang JZ, Nomura Y, Koike Y, Miyashita E. The demonstration of serum interleukin-8 and superoxide dismutase in Adamantiades-Behcet's disease. Arch Dermatol Res. 1997;289:444-447.
22. Zouboulis CC, Katsantonis J, Ketteler R, Treudler R, Kaklamani E, Hornemann S, Kaklamanis P, Orfanos CE. Adamantiades-Behcet's disease: Interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res. 2000;292:279-284.
23. Kaburaki T, Fujino Y, Kawashima H, Merino G, Numaga J, Chen J, Matsushima K. Plasma and whole-blood chemokine levels in patients with Behcet's disease. Graefes Arch Clin Exp Ophthalmol. 2003;241:353-358.
24. Harter L, Petersen F, Flad HD, Brandt E. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils: Requirement for proteolytic formation of the neutrophil-activating peptide 2. J Immunol. 1994;153:5698-5708.
25. Cochran BH, Reffel AC, Stiles CD. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell. 1983; 33:939-947.
26. Oquendo P, Alberta J, Wen DZ, Graycar JL, Derynck R, Stiles CD. The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet alpha-granule proteins. J Biol Chem. 1989;264:4133-4137.
27. 2-terminal amino acid sequence identity with melanoma growth stimulatory activity. J Exp Med. 1990;171:1091-1100.
28. Haskill S, Peace A, Morris J, Sporn SA, Anisowicz A, Lee SW, Smith T, Martin G, Ralph P, Sager R. Identification of three related human GRO genes encoding cytokine functions. Proc Natl Acad Sci U S A. 1990;87:7732-7736.
29. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8. J Exp Med. 1991;174:1355-1362.
30. Asagoe K, Yamamoto K, Takahashi A, Suzuki K, Maeda A, Nohgawa M, Harakawa N, Takano K, Mukaida N, Matsushima K, Okuma M, Sasada M. Down-regulation of CXCR2 expression on human polymorphonuclear leukocytes by TNF-alpha. J Immunol. 1998;160:4518-4525.
31. Evereklioglu C, Er H, Turkoz Y, Cekmen M. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators Inflamm. 2002;11:87-93.
32. Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986;104:847-851.